IXICO plc Further Director's Dealings

March 1, 2016

1 March 2016, IXICO plc (Ticker: IXI) ('IXICO' or the 'Company'), the brain health company, announces that it was notified on 1 March 2016 that, on the same day, Susan Lowther, Chief Financial Officer of the Company, purchased 28,366 Ordinary Shares of 1p each in IXICO at a price of 35.25p pence per Ordinary Share. 

As a consequence of this share purchase, Susan Lowther is beneficially interested in 28,366 Ordinary Shares representing 0.11% of the Company's issued share capital.



Derek Hill, CEO

Susan Lowther, CFO

+44 20 3763 7499

Peel Hunt LLP (Nominated Adviser and Broker)

James Steel / Oliver Jackson

+44 20 7418 8900


Daniel Stewart & Company (Joint Broker)

Martin Lampshire / David Coffman

+44 207 776 6550


FTI Consulting Limited (Investor Relations)

Simon Conway / Mo Noonan / Matthew Moss

+44 20 3727 1000 

Notes to Editors
IXICO's innovative and proprietary digital healthcare technologies help those involved in researching and treating serious diseases to capture and analyse clinical data to make rapid, informed decisions.  In clinical research this includes the phenotyping of patients, quantification of disease pathology and measurement of patient outcomes.  In clinical practice the mobile health and digital decision support technologies aid diagnosis, patient engagement and monitoring. IXICO is also collaborating with partners to develop companion digital health products targeted at improving patient outcomes.
The Company's brain health focus includes Alzheimer's disease, Huntington's disease, Multiple Sclerosis, behavioural health, child and adolescent mental health.